Clinical Trials Directory

Trials / Completed

CompletedNCT03127423

Comparison Between One-stage Hybrid Ablation and Thoracoscopic Surgical Ablation for Intractable Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
China National Center for Cardiovascular Diseases · Other Government
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Previous evidence indicated that the outcomes of both video-assisted thoracoscopic surgical ablation and percutaneous radiofrequency ablation therapy for persistent atrial fibrillation (AF) were unsatisfied. Recently, hybrid ablation therapy for AF had encouraging outcomes. However, there were no randomized, controlled clinical studies to prove the effectiveness of this new strategy. This study is aimed to compare the outcomes of hybrid ablation with video-assisted thoracoscopic surgical ablation for persistent AF with enlarged left atrium.

Detailed description

This study is aimed to compare the outcomes of hybrid ablation with video-assisted thoracoscopic surgical ablation for persistent AF with enlarged left atrium.

Conditions

Interventions

TypeNameDescription
PROCEDUREHybrid ablationThis intervention includes totally thoracoscopic surgical ablation and percutaneous catheter ablation simultaneously.
PROCEDUREThoracoscopic surgical ablationThis intervention only includes totally thoracoscopic surgical ablation without percutaneous catheter ablation.

Timeline

Start date
2016-12-01
Primary completion
2022-12-01
Completion
2022-12-01
First posted
2017-04-25
Last updated
2023-04-27

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03127423. Inclusion in this directory is not an endorsement.